# TARS (Tarsus Pharmaceuticals, Inc.) - SEC EDGAR Financial Statements

> Tarsus Pharmaceuticals, Inc. reported $682.2M in revenue and a net loss of $702.2M for the trailing twelve months ended September 30, 2026 (up 63.9% year over year), with a -102.0% operating margin.

- Canonical: https://convexityos.com/fundamentals/TARS
- Markdown: https://convexityos.com/fundamentals/TARS.md
- SEC CIK: 0001819790
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:18 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001819790&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $682.2M | +63.9% YoY |
| Operating Income | TTM | -$696.1M | -102.0% margin |
| Net Income | TTM | -$702.2M | -102.9% net margin |
| Diluted EPS | TTM | -$15.13 | Split-adjusted |
| Free Cash Flow | TTM | $32.44M | 4.8% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $309.6M | Total debt: $89.43M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $451.4M | $183.0M | $17.45M | $25.82M | $57.03M | $0 | -- | -- |
| Research & Development | $64.32M | $53.39M | $50.31M | $42.62M | $41.71M | $18.83M | $3.16M | -- |
| Selling, General & Admin | $427.3M | $237.3M | $108.7M | $44.95M | -- | -- | -- | -- |
| Total Operating Expenses | -- | -- | $160.6M | $88.53M | $69.18M | $27.00M | $4.30M | -- |
| **Operating Income** | -$70.97M | -$120.6M | -$143.2M | -$62.71M | -$12.16M | -$27.00M | -$4.30M | -- |
| **EBITDA** | -$69.15M | -$119.3M | -$142.3M | -$62.39M | -$11.86M | -$26.90M | -$4.26M | -- |
| Interest Income | $15.75M | $15.01M | $10.34M | $3.50M | -- | -- | -- | -- |
| Interest Expense | $8.94M | $7.85M | $3.35M | $2.20M | $0 | -- | -- | -- |
| Income Before Tax | -$64.36M | -$115.6M | -$135.9M | -$62.09M | -$13.77M | -$26.81M | -- | -- |
| Income Tax Expense | $2.06M | $0 | $0 | -$4.0K | $55K | $1.0K | $1.0K | -- |
| **Net Income** | -$66.42M | -$115.6M | -$135.9M | -$62.09M | -$13.83M | -$26.81M | -$4.67M | -$1.32M |
| Basic EPS | -$1.59 | -$3.07 | -$4.62 | -$2.52 | -$0.67 | -$4.32 | -$1.98 | -- |
| **Diluted EPS** | -$1.59 | -$3.07 | -$4.62 | -$2.52 | -$0.67 | -$4.32 | -$1.98 | -- |
| Basic Shares Outstanding | 41.8M | 37.6M | 29.4M | 24.6M | 20.6M | 6.2M | 2.4M | -- |
| Diluted Shares Outstanding | 41.8M | 37.6M | 29.4M | 24.6M | 20.6M | 6.2M | 2.4M | -- |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $194.6M | $173.9M | $162.1M | $151.7M | $118.7M | $102.7M | $78.33M | $66.41M |
| Cost of Revenue | $13.89M | $12.11M | $9.40M | -- | $8.31M | $6.24M | $5.21M | -- |
| **Gross Profit** | $180.7M | $161.8M | $152.7M | -- | $110.4M | $96.42M | $73.12M | -- |
| Research & Development | $44.19M | $31.01M | $22.35M | $18.04M | $16.28M | $15.59M | $14.41M | $16.87M |
| Selling, General & Admin | $168.0M | $150.7M | $136.4M | $130.7M | $108.6M | $103.0M | $85.00M | $69.03M |
| **Operating Income** | -$662.1M | -$19.91M | -$6.12M | -$7.98M | -$14.53M | -$22.18M | -$26.28M | -$24.42M |
| **EBITDA** | -$661.1M | -$18.91M | -$5.68M | -$7.53M | -$14.13M | -$21.78M | -$25.82M | -$23.99M |
| Interest Income | $3.78M | $3.70M | $3.72M | $3.95M | $4.11M | $4.23M | $3.45M | $3.65M |
| Interest Expense | $2.19M | $2.16M | $2.13M | $2.21M | $2.27M | $2.24M | $2.21M | $2.31M |
| Income Tax Expense | $4.64M | $2.72M | $2.35M | $2.06M | $0 | $0 | $0 | -- |
| **Net Income** | -$668.3M | -$18.55M | -$6.97M | -$8.37M | -$12.59M | -$20.34M | -$25.12M | -$23.11M |
| Basic EPS | -$14.40 | -$0.43 | -$0.16 | -- | -$0.30 | -$0.48 | -$0.64 | -- |
| **Diluted EPS** | -$14.40 | -$0.43 | -$0.16 | -- | -$0.30 | -$0.48 | -$0.64 | -- |
| Basic Shares Outstanding | 46.4M | 43.4M | 43.0M | -- | 42.6M | 42.4M | 39.3M | -- |
| Diluted Shares Outstanding | 46.4M | 43.4M | 43.0M | -- | 42.6M | 42.4M | 39.3M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $183.6M | $94.82M | $224.9M | $71.66M | $171.3M | $168.1M | $57.95M |
| Short-Term Investments | $233.6M | $196.6M | $2.50M | $145.4M | $483K | $0 | -- |
| **Cash & Short-Term Investments** | $417.3M | $291.4M | $227.4M | $217.0M | $171.8M | $168.1M | $57.95M |
| Accounts Receivable, Net | $85.06M | $46.76M | $16.62M | $0 | $0 | $0 | -- |
| Inventory | $4.37M | $2.62M | $3.11M | $0 | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- | -- | $0 |
| **Total Current Assets** | $522.8M | $356.7M | $256.1M | $225.4M | $176.0M | $170.7M | $58.03M |
| Property, Plant & Equipment, Net | $11.66M | $2.31M | $1.47M | $957K | $755K | $548K | $154K |
| Intangible Assets | $7.37M | $8.33M | $3.87M | $0 | -- | -- | -- |
| Long-Term Investments | $3.87M | $3.00M | $631K | $371K | $0 | -- | -- |
| Other Non-Current Assets | $1.86M | $999K | $1.51M | $585K | $1.13M | $81K | $6.0K |
| **Total Non-Current Assets** | $39.38M | $20.29M | $9.36M | $2.49M | $2.96M | $1.32M | $286K |
| **Total Assets** | $562.2M | $377.0M | $265.5M | $227.9M | $178.9M | $172.0M | $58.32M |
| Accounts Payable | $16.39M | $9.42M | $17.77M | $5.50M | $2.86M | $2.24M | $456K |
| Deferred Revenue (Current) | -- | -- | -- | $0 | $697K | $0 | -- |
| Other Current Liabilities | $16.31M | $18.32M | -- | -- | -- | -- | -- |
| **Total Current Liabilities** | $135.7M | $80.61M | $36.94M | $15.43M | $11.48M | $5.39M | $819K |
| Long-Term Debt | $72.44M | $71.84M | $29.82M | $19.43M | $0 | -- | -- |
| Other Non-Current Liabilities | $10.60M | $0 | $1.75M | $100K | $699K | $605K | $100K |
| **Total Non-Current Liabilities** | $83.04M | $71.84M | $31.57M | $19.53M | $699K | $605K | $100K |
| **Total Liabilities** | $218.7M | $152.5M | $68.50M | $34.96M | $12.18M | $5.99M | $919K |
| **Total Debt (incl. Leases)** | $83.04M | $72.45M | $31.73M | $20.32M | $1.19M | $831K | $164K |
| Common Stock | $6.0K | $6.0K | $5.0K | $5.0K | $4.0K | $4.0K | $2.0K |
| Retained Earnings | -$426.6M | -$360.2M | -$244.7M | -$108.8M | -$46.67M | -$32.84M | -$6.03M |
| Accumulated Other Comp. Income | $381K | $179K | -$2.0K | -$74K | $0 | -- | -- |
| **Total Stockholders' Equity** | $343.4M | $224.5M | $197.0M | $192.9M | $166.7M | $166.0M | -$6.00M |
| Total Equity | $343.4M | $224.5M | $197.0M | $192.9M | $166.7M | $166.0M | -$6.00M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $136.5M | $204.6M | $102.2M | $183.6M | $112.7M | $96.65M | $175.8M | $94.82M |
| Short-Term Investments | $173.1M | $245.1M | $286.5M | $233.6M | $289.1M | $284.5M | $232.1M | $196.6M |
| **Cash & Short-Term Investments** | $309.6M | $449.7M | $388.7M | $417.3M | $401.8M | $381.1M | $407.9M | $291.4M |
| Accounts Receivable, Net | $100.4M | $96.03M | $100.3M | $85.06M | $72.62M | $58.33M | $62.43M | $46.76M |
| Inventory | $5.16M | $4.38M | $4.57M | $4.37M | $3.84M | $3.87M | $2.71M | $2.62M |
| **Total Current Assets** | $445.4M | $562.0M | $537.2M | $522.8M | $501.7M | $474.4M | $480.8M | $356.7M |
| Property, Plant & Equipment, Net | $20.72M | $20.49M | $17.67M | $11.66M | $5.75M | $3.18M | $2.79M | $2.31M |
| Intangible Assets | $16.64M | $6.88M | $7.13M | $7.37M | $7.61M | $7.85M | $8.09M | $8.33M |
| Long-Term Investments | $6.68M | $6.68M | $3.87M | $3.87M | $3.00M | $3.00M | $3.00M | $3.00M |
| Other Non-Current Assets | $735K | $660K | $715K | $1.86M | $1.18M | $1.21M | $616K | $999K |
| **Total Non-Current Assets** | $60.08M | $49.15M | $43.91M | $39.38M | $32.86M | $20.57M | $19.98M | $20.29M |
| **Total Assets** | $505.5M | $611.1M | $581.1M | $562.2M | $534.6M | $495.0M | $500.8M | $377.0M |
| Accounts Payable | $34.69M | $40.14M | $24.13M | $16.39M | $40.64M | $28.07M | $28.38M | $9.42M |
| Other Current Liabilities | $32.15M | $25.43M | $32.50M | $16.31M | -- | -- | -- | $18.32M |
| **Total Current Liabilities** | $227.1M | $175.8M | $143.5M | $135.7M | $117.0M | $90.25M | $86.31M | $80.61M |
| Long-Term Debt | $72.94M | $72.76M | $72.60M | $72.44M | $72.28M | $72.13M | $71.98M | $71.84M |
| Other Non-Current Liabilities | $15.73M | $15.89M | $16.08M | $10.60M | $10.15M | -- | -- | $0 |
| **Total Non-Current Liabilities** | $174.4M | $88.66M | $88.68M | $83.04M | $82.43M | $72.13M | $71.98M | $71.84M |
| **Total Liabilities** | $401.5M | $264.4M | $232.2M | $218.7M | $199.5M | $162.4M | $158.3M | $152.5M |
| **Total Debt (incl. Leases)** | $89.43M | $88.81M | $88.68M | $83.04M | $82.51M | $72.45M | $72.37M | $72.45M |
| Common Stock | $7.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K | $6.0K |
| Retained Earnings | -$1.12B | -$452.1M | -$433.6M | -$426.6M | -$418.3M | -$405.7M | -$385.3M | -$360.2M |
| Accumulated Other Comp. Income | -$914K | -$557K | -$298K | $381K | $289K | $39K | $85K | $179K |
| **Total Stockholders' Equity** | $104.0M | $346.7M | $349.0M | $343.4M | $335.1M | $332.6M | $342.5M | $224.5M |
| Total Equity | $104.0M | $346.7M | $349.0M | $343.4M | $335.1M | $332.6M | $342.5M | $224.5M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$66.42M | -$115.6M | -$135.9M | -$62.09M | -$13.83M | -$26.81M | -$4.67M | -$1.32M |
| Depreciation & Amortization | $1.82M | $1.23M | $877K | $326K | $300K | $100K | $37K | -- |
| Stock-Based Compensation | $41.72M | $27.82M | $19.83M | $13.46M | $8.46M | $839K | $18K | -- |
| Change in Receivables | -$38.30M | -$30.14M | -$16.62M | $0 | -- | -- | -- | -- |
| Change in Inventory | -$1.75M | -$2.05M | -$3.11M | $0 | -- | -- | -- | -- |
| **Operating Cash Flow** | -$12.45M | -$83.03M | -$117.5M | -$49.03M | $3.75M | -$21.14M | -$3.67M | -- |
| Capital Expenditure | -$9.86M | -$1.57M | -$1.50M | -$506K | -$586K | -$456K | -$175K | -- |
| **Free Cash Flow** | -$22.31M | -$84.59M | -$119.0M | -$49.54M | $3.16M | -$21.59M | -$3.85M | -- |
| Purchases of Investments | -$393.2M | -$262.6M | -$28.66M | -$149.4M | $0 | -- | -- | -- |
| **Investing Cash Flow** | -$42.12M | -$199.2M | $140.6M | -$144.6M | -$586K | -$456K | -$175K | -- |
| **Financing Cash Flow** | $143.4M | $154.7M | $130.2M | $93.99M | $21K | $131.8M | $59.45M | -- |
| **Net Change in Cash** | $88.82M | -$127.6M | $153.3M | -$99.67M | $3.18M | $110.2M | $55.60M | -- |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$668.3M | -$18.55M | -$6.97M | -$8.37M | -$12.59M | -$20.34M | -$25.12M | -$23.11M |
| Depreciation & Amortization | $1.00M | $1.00M | $437K | $443K | $400K | $400K | $460K | $432K |
| Stock-Based Compensation | $27.22M | $13.29M | $11.97M | $14.31M | $12.24M | $8.23M | $6.93M | $7.40M |
| Change in Receivables | -$4.41M | $19.32M | -$30.29M | -$12.44M | -$14.29M | $4.09M | -$15.67M | -$17.60M |
| Change in Inventory | -$781K | $198K | -$196K | -$536K | $37K | -$1.17M | -$84K | $227K |
| **Operating Cash Flow** | -$6.00M | $61.22M | -$24.65M | $19.33M | $18.26M | -$29.39M | -$20.65M | -$22.18M |
| Capital Expenditure | -$1.21M | -$4.07M | -$5.82M | -$6.36M | -$1.91M | -$1.00M | -$590K | -$72K |
| **Free Cash Flow** | -$7.21M | $57.15M | -$30.47M | $12.97M | $16.35M | -$30.39M | -$21.24M | -$22.25M |
| Purchases of Investments | $0 | -$2.40M | -$126.8M | -$35.58M | -$102.3M | -$129.7M | -$125.6M | -$89.97M |
| **Investing Cash Flow** | -$189.5M | $37.88M | -$58.56M | $49.27M | -$4.74M | -$51.70M | -$34.94M | -$59.57M |
| Common Stock Issued | $113.1M | $0 | $0 | -- | $0 | -$354K | $135.1M | -- |
| **Financing Cash Flow** | $127.8M | $3.30M | $1.20M | $2.31M | $2.56M | $1.95M | $136.6M | $2.93M |
| **Net Change in Cash** | -$67.68M | $102.4M | -$82.01M | $70.92M | $16.08M | -$79.14M | $80.97M | -$78.83M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 | FY 2018 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -15.7% | -65.9% | -820.5% | -242.9% | -21.3% | -- | -- | -- |
| **Net Profit Margin** | -14.7% | -63.2% | -778.9% | -240.5% | -24.2% | -- | -- | -- |
| Return on Equity (ROE) | -19.3% | -51.5% | -69.0% | -32.2% | -8.3% | -16.2% | -- | -- |
| Return on Assets (ROA) | -11.8% | -30.7% | -51.2% | -27.2% | -7.7% | -15.6% | -8.0% | -- |
| Current Ratio | 3.85x | 4.42x | 6.93x | 14.61x | 15.33x | 31.68x | 70.85x | -- |
| Quick Ratio | 3.82x | 4.39x | 6.85x | 14.61x | 14.97x | 31.21x | 70.76x | -- |
| Debt to Equity | 0.24x | 0.32x | 0.16x | 0.11x | 0.01x | 0.01x | -- | -- |
| **Revenue Growth (YoY)** | +146.7% | +948.6% | -32.4% | -54.7% | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -- | -- | -- | -1408.2% | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -- | -- | -- | -1666.6% | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -102.0% | -8.0% | -9.5% | -15.7% | -23.9% | -33.2% | -46.7% | -65.9% |
| **Net Profit Margin** | -102.9% | -7.7% | -9.0% | -14.7% | -22.2% | -31.1% | -44.9% | -63.2% |
| Return on Equity (ROE) | -675.0% | -13.4% | -13.8% | -19.3% | -24.2% | -27.7% | -30.6% | -51.5% |
| Return on Assets (ROA) | -138.9% | -7.6% | -8.3% | -11.8% | -15.2% | -18.6% | -21.0% | -30.7% |
| Current Ratio | 1.96x | 3.20x | 3.74x | 3.85x | 4.29x | 5.26x | 5.57x | 4.42x |
| Quick Ratio | 1.94x | 3.17x | 3.71x | 3.82x | 4.25x | 5.21x | 5.54x | 4.39x |
| Debt to Equity | 0.86x | 0.26x | 0.25x | 0.24x | 0.25x | 0.22x | 0.21x | 0.32x |
| **Revenue Growth (YoY)** | +63.9% | +69.4% | +106.9% | +128.4% | +146.7% | +151.5% | +183.7% | +407.9% |
| Gross Profit Growth (YoY) | +63.7% | +67.8% | +108.8% | -- | -- | -- | -- | -- |
| Operating Cash Flow Growth (YoY) | -132.9% | -- | -- | -- | -- | -- | -- | -- |
| Free Cash Flow Growth (YoY) | -144.1% | -- | -- | -- | -- | -- | -- | -- |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
